Deutsch  English 

 

Mistletoe in Tumour Therapy

B A S I C   R E S E A R C H    A N D    C L I N I C A L    P R A C T I C E

9th M i s t l e t o e   S y m p o s i u m

4 - 6 November 2027

and

Integrated   P r e s e n c e   and   O n l i n e   F u r t h e r   T r a i n i n g

P r a c t i s e   o f   M i s t l e t o e   T h e r a p y

on 5 November 2027, 5.00 - 9.45 p.m.

Europäische Akademie Otzenhausen, D-66620 Nonnweiler www.eao-otzenhausen.de/en/

1st A n n o u n c e m e n t

Organizers:

Association of Anthroposophic Doctors in Germany,
Society for Phytotherapy,
Zentralverband der Ärzte für Naturheilverfahren u. Regulationsmedizin (ZAEN)

Co-operation Partners:

APV The International Association for Pharmaceutical Technology,
Deutsche Pharmazeutische Gesellschaft (German Pharmaceutical Society),
European Society for Integrative Oncology, 
Society for Medicinal Plant and Natural Product Research

Funding by foundations:

Karl and Veronica Carstens Foundation

Scientific Organizing Committee:

Dr. Rainer Scheer, Niefern-Öschelbronn (Director); Prof. Dr. Harald Matthes, Berlin (Director); Prof. Dr. Susanne Alban, Kiel; Prof. Dr. Reinhild Klein, Tübingen; Prof. Dr. Wolfgang Kreis, Hemhofen; PD Dr. Ann-Kathrin Lederer, Ulm; PD Dr. Gero Leneweit, Niefern-Öschelbronn; Dr. Emanuela Portalupi, Mailand (Italien); Sabine Rieger, Balingen; Dr. Günther Spahn, Mainz; Dr. Rainer Stange, Berlin.

Objectives:

Every four years, these symposiums on mistletoe-which we organize-provide a forum for discussion that has been proven over more than 30 years and serve as the foundation for a broad scientific discourse and the exchange of clinical experiences. The clinical session of this current symposium will focus on Mistletoe in the Context of Modern Immunotherapies and Multimodal Treatment Approaches in Integrative Oncology and the Role of Mistletoe within them. New findings and therapeutic approaches in oncology continually open up new options for the use and further development of mistletoe therapy. We cordially invite you to attend.

Dear colleagues,

We kindly invite you to actively participate in the Mistletoe Symposium and share your experiences and knowledge with your colleagues. To do so, please submit your current scientific contributions (short lectures and/or posters) on basic research and the clinical application of Mistletoe in Tumour Therapy.

The program for the 9th Mistletoe Symposium will be finalized in mid-2027 based on your submitted contributions. Please find some example topics listed below:

  • Botany, physiology, pharmacy and phytochemistry: appropriate standardisation, assurance of pharmaceutical quality of mistletoe preparations, their analytics and galenic.
  • Immunology, pre-clinic, cytotoxicity, mode of action profile of the active ingredients and total extracts
  • Tumour-specific application: clinical efficacy in malignant diseases, in benign tumours, for recurrence prevention following tumour surgery, in defined precancerous disorders, and the influence of mistletoe therapy on metastasis
  • Posology, mode of application: Dosing regimens and therapeutic range, effects of the route of administration on the therapeutic range
  • Immune parameters before and during mistletoe therapy; immune status; follow-up parameters for monitoring mistletoe therapy
  • Clinical research and proof of efficacy: clinical studies with mistletoe, objective criteria for proof of efficacy, further developments in mistletoe therapy
  • Health services research data/Real World Data on outcome, tolerability, safety and cost-effectiveness, pharmacoeconomics
  • Drug safety: analysis of side effects with regard to effect and efficacy, type and frequency of adverse drug reactions, pseudo allergic reactions
  • Meta-analyses; systematic reviews and their evaluation
  • Regulatory issues

Overview presentations by invited speakers will be given on selected topics (in bold).

The abstracts of all symposium contributions will be published in the Journal of Integrative and Complementary Medicine and will be available online at the symposium date. All symposium participants will receive access to the abstracts and, upon request, a printed copy.

Participation in the Mistletoe Symposium and the hybrid training programme, cost contribution:

The Mistletoe Symposium will take place in person with a training programme on Friday, which can also be attended online. The number of participants and contributions in the scientific part of the symposium is limited. The decision on the acceptance of contributions and their form of presentation is the responsibility of the Scientific Organizing Committee.

No event fees will be charged for participation in the Mistletoe Symposium. Travel, accommodation and meals on site must be paid for by each participant.

Language:

The symposium will be held in German. Simultaneous translation into English will be provided for all presentations, including contributions to the discussion.

Lectures may also be given in English, and posters should be presented in English.

Publication of conference proceedings:

After the symposium, all contributions will be published in conference proceedings as soon as possible. We therefore ask authors to submit a print-ready manuscript of their contribution by 31 January 2028.

The guidelines for authors of book articles are available at www.mistelsymposium.de.

Continuing education credits:

Certification and accreditation as a continuing education event by the Saarland Medical Association (Landesärztekammer) and Saarland Chamber of Pharmacists (Landesapothekerkammer) will also be applied for the 9th Mistletoe Symposium.

For further information and for written registration please contact:

Dr. Rainer Scheer, Carl Gustav Carus-Institut, Allmendstr. 55, D-75223 Niefern-Öschelbronn
Tel. +49 7233 7043-118, Fax +49 7233 7043-110, E-mail: rainer.scheer@carus-institut.de

Please follow the instructions on our website www.mistelsymposium.de

Subject to alterations

 

Niefern-Öschelbronn, June 2026                                                         Dr. Rainer Scheer

CLICK here for DOWNLOAD First Announcement